| 1 | The AβA2V paradigm: From molecular insights to therapeutic strategies in Alzheimer’s disease and primary tauopathies | 6.3 | 1 | Citations (PDF) |
| 2 | A cutting-edge approach based on UHPLC-MS to simultaneously investigate oxysterols and cholesterol precursors in biological samples: Validation in Huntington's disease mouse model | 3.2 | 4 | Citations (PDF) |
| 3 | Variations in Biodistribution and Acute Response of Differently Shaped Titania Nanoparticles in Healthy Rodents | 3.0 | 2 | Citations (PDF) |
| 4 | Effect of Non-Nutritive Sweeteners on the Gut Microbiota | 3.2 | 76 | Citations (PDF) |
| 5 | Aβ1-6A2V(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury | 5.2 | 19 | Citations (PDF) |
| 6 | A Comprehensive Technology Platform for the Rapid Discovery of Peptide Inhibitors against SARS-CoV-2 Pseudovirus Infection | 3.2 | 6 | Citations (PDF) |
| 7 | Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2 | 4.7 | 32 | Citations (PDF) |
| 8 | Antitumour drugs targeting tau R3 VQIVYK and Cys322 prevent seeding of endogenous tau aggregates by exogenous seeds | 3.3 | 12 | Citations (PDF) |
| 9 | The mode of dexamethasone decoration influences avidin-nucleic-acid-nano-assembly organ biodistribution and in vivo drug persistence | 2.3 | 6 | Citations (PDF) |
| 10 | Biochemical and biophysical features of disease-associated tau mutants V363A and V363I | 1.3 | 1 | Citations (PDF) |
| 11 | Toxicological impact of titanium dioxide nanoparticles and food-grade titanium dioxide (E171) on human and environmental health | 3.1 | 53 | Citations (PDF) |
| 12 | Apelin Resistance Contributes to Muscle Loss during Cancer Cachexia in Mice | 2.7 | 10 | Citations (PDF) |
| 13 | A Nanoscale Shape-Discovery Framework Supporting Systematic Investigations of Shape-Dependent Biological Effects and Immunomodulation | 11.5 | 25 | Citations (PDF) |
| 14 | Food-Grade Titanium Dioxide Induces Toxicity in the Nematode Caenorhabditis elegans and Acute Hepatic and Pulmonary Responses in Mice | 3.0 | 15 | Citations (PDF) |
| 15 | NMR-Driven Identification of Cinnamon Bud and Bark Components With Anti-Aβ Activity | 3.1 | 18 | Citations (PDF) |
| 16 | A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease | 5.2 | 15 | Citations (PDF) |
| 17 | Dysmyelination and glycolipid interference caused by phenylalanine in phenylketonuria | 5.6 | 14 | Citations (PDF) |
| 18 | Micro- and Nanoplastics’ Effects on Protein Folding and Amyloidosis | 3.2 | 53 | Citations (PDF) |
| 19 | Cytoskeleton Elements Contribute to Prion Peptide-Induced Endothelial Barrier Breakdown in a Blood–Brain Barrier In Vitro System | 3.2 | 0 | Citations (PDF) |
| 20 | Alzheimer’s Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity | 2.7 | 25 | Citations (PDF) |
| 21 | NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa’s anti-amyloidogenic activity | 8.0 | 21 | Citations (PDF) |
| 22 | Sleep inhibition induced by amyloid‐β oligomers is mediated by the cellular prion protein | 2.8 | 9 | Citations (PDF) |
| 23 | Nonphosphorylated tau slows down Aβ1–42 aggregation, binds to Aβ1–42 oligomers, and reduces Aβ1–42 toxicity | 1.3 | 8 | Citations (PDF) |
| 24 | The similarity of inherited diseases (I): clinical similarity within the phenotypic series | 1.3 | 1 | Citations (PDF) |
| 25 | Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease | 8.1 | 58 | Citations (PDF) |
| 26 | Can Antiviral Activity of Licorice Help Fight COVID-19 Infection? | 3.1 | 30 | Citations (PDF) |
| 27 | N-Terminally Truncated and Pyroglutamate-Modified Aβ Forms Are Measurable in Human Cerebrospinal Fluid and Are Potential Markers of Disease Progression in Alzheimer’s Disease | 2.0 | 20 | Citations (PDF) |
| 28 | Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity | 2.2 | 2 | Citations (PDF) |
| 29 | Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin | 5.2 | 8 | Citations (PDF) |
| 30 | Flavonoid‐Derived Human Phenyl‐γ‐Valerolactone Metabolites Selectively Detoxify Amyloid‐β Oligomers and Prevent Memory Impairment in a Mouse Model of Alzheimer's Disease | 2.7 | 36 | Citations (PDF) |
| 31 | Efficacy of Cholesterol Nose-to-Brain Delivery for Brain Targeting in Huntington’s Disease | 2.7 | 39 | Citations (PDF) |
| 32 | The similarity of inherited diseases (II): clinical and biological similarity between the phenotypic series | 1.3 | 4 | Citations (PDF) |
| 33 | Aβ Beyond the AD Pathology: Exploring the Structural Response of Membranes Exposed to Nascent Aβ Peptide | 3.2 | 7 | Citations (PDF) |
| 34 | Selenoprotein N is an endoplasmic reticulum calcium sensor that links luminal calcium levels to a redox activity | 5.2 | 67 | Citations (PDF) |
| 35 | Neuronal Localization of SENP Proteins with Super Resolution Microscopy | 1.8 | 14 | Citations (PDF) |
| 36 | Quantitative analysis of proteins which are members of the same protein complex but cause locus heterogeneity in disease | 2.7 | 5 | Citations (PDF) |
| 37 | A portable optical-fibre-based surface plasmon resonance biosensor for the detection of therapeutic antibodies in human serum | 2.7 | 126 | Citations (PDF) |
| 38 | Increased transcription of transglutaminase 1 mediates neuronal death in in vitro models of neuronal stress and Aβ1–42-mediated toxicity | 3.5 | 21 | Citations (PDF) |
| 39 | Synthesis and Molecular Modelling Studies of New 1,3-Diaryl-5-Oxo-Proline Derivatives as Endothelin Receptor Ligands | 3.2 | 2 | Citations (PDF) |
| 40 | Cellulose Nanocrystals: A Multimodal Tool to Enhance The Targeted Drug Delivery Against Bone Disorders | 2.5 | 9 | Citations (PDF) |
| 41 | Super-Resolution Imaging to Study Co-Localization of Proteins and Synaptic Markers in Primary Neurons | 0.2 | 2 | Citations (PDF) |
| 42 | Super-Resolution Imaging to Study Co-Localization of Proteins and Synaptic Markers in Primary Neurons | 0.2 | 0 | Citations (PDF) |
| 43 | Super Resolution Microscopy of SUMO Proteins in Neurons | 2.4 | 26 | Citations (PDF) |
| 44 | [1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor | 4.4 | 4 | Citations (PDF) |
| 45 | The Anti-Amyloidogenic Action of Doxycycline: A Molecular Dynamics Study on the Interaction with Aβ42 | 3.2 | 42 | Citations (PDF) |
| 46 | Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model | 11.5 | 58 | Citations (PDF) |
| 47 | A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies | 2.7 | 80 | Citations (PDF) |
| 48 | Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder | 2.7 | 20 | Citations (PDF) |
| 49 | Monitoring the Fate of Orally Administered PLGA Nanoformulation for Local Delivery of Therapeutic Drugs | 4.2 | 33 | Citations (PDF) |
| 50 | Plasma and Brain Concentrations of Doxycycline after Single and Repeated Doses in Wild-Type and APP23 Mice | 2.3 | 63 | Citations (PDF) |
| 51 | Review: PrP 106‐126 – 25 years after | 1.9 | 35 | Citations (PDF) |
| 52 | bioNMR-based identification of natural anti-Aβ compounds in Peucedanum ostruthium | 3.4 | 35 | Citations (PDF) |
| 53 | Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants | 1.6 | 27 | Citations (PDF) |
| 54 | In Situ Tissue Labeling of Cerebral Amyloid Using HIV-Related Tat Peptide | 3.0 | 13 | Citations (PDF) |
| 55 | Mutagenicity, anticancer activity and blood brain barrier: similarity and dissimilarity of molecular alerts | 1.5 | 12 | Citations (PDF) |
| 56 | NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts | 8.0 | 56 | Citations (PDF) |
| 57 | Use of quasi-SMILES to model biological activity of “micelle–polymer” samples | 1.4 | 11 | Citations (PDF) |
| 58 | Translational Research in Alzheimer’s and Prion Diseases | 1.6 | 8 | Citations (PDF) |
| 59 | V363I and V363A mutated tau affect aggregation and neuronal dysfunction differently in C. elegans | 3.5 | 15 | Citations (PDF) |
| 60 | Realistic Evaluation of Titanium Dioxide Nanoparticle Exposure in Chewing Gum | 4.5 | 41 | Citations (PDF) |
| 61 | Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models | 2.4 | 79 | Citations (PDF) |
| 62 | p17 from HIV induces brain endothelial cell angiogenesis through EGFR-1-mediated cell signalling activation | 1.8 | 13 | Citations (PDF) |
| 63 | Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer’s disease | 3.4 | 162 | Citations (PDF) |
| 64 | Cardiac Light Chain Amyloidosis: The Role of Metal Ions in Oxidative Stress and Mitochondrial Damage | 4.1 | 62 | Citations (PDF) |
| 65 | Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept | 3.3 | 39 | Citations (PDF) |
| 66 | QSAR model for blood-brain barrier permeation | 1.4 | 40 | Citations (PDF) |
| 67 | Pathogenic Aβ A2V versus protective Aβ A2T mutation: Early stage aggregation and membrane interaction | 1.4 | 18 | Citations (PDF) |
| 68 | Applicability of [ 11 C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model | 2.4 | 18 | Citations (PDF) |
| 69 | Influence of Size and Shape on the Anatomical Distribution of Endotoxin-Free Gold Nanoparticles | 11.5 | 178 | Citations (PDF) |
| 70 | Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry | 2.7 | 84 | Citations (PDF) |
| 71 | A simple headspace gas chromatography/mass spectrometry method for the quantitative determination of the release of the antioxidants butylated hydroxyanisole and butylated hydroxytoluene from chewing gum | 1.1 | 21 | Citations (PDF) |
| 72 | Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their
in vivo
Toxicity | 1.6 | 28 | Citations (PDF) |
| 73 | New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT7 and 5-HT1A receptor ligands: Synthesis, structure-activity relationships, and molecular modeling studies | 2.1 | 24 | Citations (PDF) |
| 74 | Biocompatible Polymer Nanoformulation To Improve the Release and Safety of a Drug Mimic Molecule Detectable via ICP-MS | 3.2 | 22 | Citations (PDF) |
| 75 | HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders | 2.7 | 36 | Citations (PDF) |
| 76 | The A2V mutation as a new tool for hindering Aβ aggregation: A neutron and x-ray diffraction study | 2.7 | 12 | Citations (PDF) |
| 77 | Single particle extinction and scattering optical method unveils in real time the influence of the blood components on polymeric nanoparticles | 2.3 | 9 | Citations (PDF) |
| 78 | Flavonoids and Their Glycosides as Anti‐amyloidogenic Compounds: Aβ1–42 Interaction Studies to Gain New Insights into Their Potential for Alzheimer's Disease Prevention and Therapy | 2.1 | 38 | Citations (PDF) |
| 79 | The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers | 1.6 | 15 | Citations (PDF) |
| 80 | Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to Bortezomib | 1.5 | 50 | Citations (PDF) |
| 81 | Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR | 1.5 | 19 | Citations (PDF) |
| 82 | Synthesis and Preliminary Biological Evaluation of Fluorescent Glycofused Tricyclic Derivatives of Amyloid β‐Peptide Ligands | 1.7 | 8 | Citations (PDF) |
| 83 | Structural Modifications of cis‐Glycofused Benzopyran Compounds and Their Influence on the Binding to Amyloid‐β Peptide | 2.1 | 21 | Citations (PDF) |
| 84 | Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β | 2.7 | 34 | Citations (PDF) |
| 85 | Amyloidβ Peptides in interaction with raft-mime model membranes: a neutron reflectivity insight | 2.7 | 33 | Citations (PDF) |
| 86 | Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study | 2.7 | 51 | Citations (PDF) |
| 87 | Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 | 2.7 | 23 | Citations (PDF) |
| 88 | Monte Carlo method for predicting of cardiac toxicity: hERG blocker compounds | 0.4 | 32 | Citations (PDF) |
| 89 | Beta‐amyloid 1‐42 monomers, but not oligomers, produce
PHF
‐like conformation of Tau protein | 4.8 | 32 | Citations (PDF) |
| 90 | Pulmonary administration of functionalized nanoparticles significantly reduces beta-amyloid in the brain of an Alzheimer’s disease murine model | 6.7 | 16 | Citations (PDF) |
| 91 | The new β amyloid-derived peptide Aβ1–6A2V-TAT(D) prevents Aβ oligomer formation and protects transgenic C. elegans from Aβ toxicity | 3.5 | 22 | Citations (PDF) |
| 92 | An Early Developmental Vertebrate Model for Nanomaterial Safety: Bridging Cell-Based and Mammalian Toxicity Assessment | 2.5 | 21 | Citations (PDF) |
| 93 | Internalization of nanopolymeric tracers does not alter characteristics of placental cells | 2.4 | 4 | Citations (PDF) |
| 94 | The cell-permeable Aβ1-6A2VTAT(D) peptide reverts synaptopathy induced by Aβ1-42wt | 3.5 | 21 | Citations (PDF) |
| 95 | Clusterin Binds to Aβ1–42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation | 1.3 | 123 | Citations (PDF) |
| 96 | Fate of PLA and PCL-Based Polymeric Nanocarriers in Cellular and Animal Models of Triple-Negative Breast Cancer | 3.8 | 25 | Citations (PDF) |
| 97 | The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease | 2.3 | 52 | Citations (PDF) |
| 98 | Doxycycline hinders phenylalanine fibril assemblies revealing a potential novel therapeutic approach in phenylketonuria | 2.7 | 39 | Citations (PDF) |
| 99 | Investigation of Functionalized Poly(N,N‐dimethylacrylamide)‐block‐polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood–Brain Barrier In Vitro | 2.7 | 26 | Citations (PDF) |
| 100 | NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease | 2.1 | 23 | Citations (PDF) |
| 101 | Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT1A and 5-HT7 receptor ligands | 1.5 | 28 | Citations (PDF) |
| 102 | Organ Distribution and Bone Tropism of Cellulose Nanocrystals in Living Mice | 3.8 | 80 | Citations (PDF) |
| 103 | Multigram Synthesis and in Vivo Efficacy Studies of a Novel Multitarget Anti-Alzheimer’s Compound | 3.2 | 21 | Citations (PDF) |
| 104 | Longitudinal tracking of triple labeled umbilical cord derived mesenchymal stromal cells in a mouse model of Amyotrophic Lateral Sclerosis | 0.3 | 22 | Citations (PDF) |
| 105 | Chemerin Produced By Mesenchymal Stromal Cells (MSC) Is an Important Factor for In Vivo macrophage MigrationBlood, 2015, 126, 1195-1195 | 3.6 | 0 | Citations (PDF) |
| 106 | Cis‐Glyco‐Fused Benzopyran Derivatives as Hit Compounds for the Development of Therapeutic and Diagnostic Tools against Neurodegenerative Diseases | 2.1 | 20 | Citations (PDF) |
| 107 | Multifunctional Liposomes Reduce Brain β-Amyloid Burden and Ameliorate Memory Impairment in Alzheimer's Disease Mouse Models | 2.3 | 163 | Citations (PDF) |
| 108 | A New Surface Plasmon Resonance-Based Immunoassay for Rapid, Reproducible and Sensitive Quantification of Pentraxin-3 in Human Plasma | 2.3 | 24 | Citations (PDF) |
| 109 | A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma | 1.9 | 24 | Citations (PDF) |
| 110 | Integrated multiplatform method forin vitroquantitative assessment of cellular uptake for fluorescent polymer nanoparticles | 1.9 | 21 | Citations (PDF) |
| 111 | Blood protein coating of gold nanoparticles as potential tool for organ targeting | 9.5 | 125 | Citations (PDF) |
| 112 | Determination of tissue levels of a neuroprotectant drug: The cell permeable JNK inhibitor peptide | 1.4 | 19 | Citations (PDF) |
| 113 | Monomeric Aβ1–42 and RAGE: key players in neuronal differentiation | 2.4 | 30 | Citations (PDF) |
| 114 | Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation | 3.5 | 131 | Citations (PDF) |
| 115 | Synthesis and evaluation of a 18F-curcumin derivate for β-amyloid plaque imaging | 2.1 | 37 | Citations (PDF) |
| 116 | Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial | 13.7 | 190 | Citations (PDF) |
| 117 | Targeting Dopamine D3and Serotonin 5-HT1Aand 5-HT2AReceptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies | 4.0 | 49 | Citations (PDF) |
| 118 | The Peculiar Role of the A2V Mutation in Amyloid-β (Aβ) 1–42 Molecular Assembly | 1.3 | 58 | Citations (PDF) |
| 119 | Natural Compounds against Neurodegenerative Diseases: Molecular Characterization of the Interaction of Catechins from Green Tea with Aβ1–42, PrP106–126, and Ataxin‐3 Oligomers | 2.4 | 44 | Citations (PDF) |
| 120 | Structure–activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT7 and 5-HT1A receptor ligands | 4.4 | 40 | Citations (PDF) |
| 121 | In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [18F]flutemetamol | 1.6 | 23 | Citations (PDF) |
| 122 | An integrated approach for the systematic evaluation of polymeric nanoparticles in healthy and diseased organisms | 2.3 | 14 | Citations (PDF) |
| 123 | c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo | 6.6 | 104 | Citations (PDF) |
| 124 | In Vivo Fate of Avidin-Nucleic Acid Nanoassemblies as Multifunctional Diagnostic Tools | 11.5 | 40 | Citations (PDF) |
| 125 | Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features | 2.4 | 40 | Citations (PDF) |
| 126 | Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity | 3.5 | 32 | Citations (PDF) |
| 127 | A Caenorhabditis elegans–based assay recognizes immunoglobulin light chains causing heart amyloidosisBlood, 2014, 123, 3543-3552 | 3.6 | 153 | Citations (PDF) |
| 128 | Chemerin As a New Potential Player in the Immunoregulatory Activity of Mesenchymal Stromal CellsBlood, 2014, 124, 1590-1590 | 3.6 | 0 | Citations (PDF) |
| 129 | Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis | 2.6 | 28 | Citations (PDF) |
| 130 | Novel approaches for studying amyloidogenic peptides/proteins | 2.8 | 18 | Citations (PDF) |
| 131 | Biocompatible fluorescent nanoparticles forin vivostem cell tracking | 1.9 | 32 | Citations (PDF) |
| 132 | Fluorescent amyloid β-peptide ligand derivatives as potential diagnostic tools for Alzheimer’s disease | 0.9 | 12 | Citations (PDF) |
| 133 | Soluble Aβ oligomer-induced synaptopathy: c-Jun N-terminal kinase's role | 2.9 | 32 | Citations (PDF) |
| 134 | Longitudinal Amyloid Imaging in Mouse Brain with 11C-PIB: Comparison of APP23, Tg2576, and APPswe-PS1dE9 Mouse Models of Alzheimer Disease | 4.0 | 81 | Citations (PDF) |
| 135 | Oleuropein Aglycone Protects Transgenic C. elegans Strains Expressing Aβ42 by Reducing Plaque Load and Motor Deficit | 1.5 | 139 | Citations (PDF) |
| 136 | PaCS Is a Novel Cytoplasmic Structure Containing Functional Proteasome and Inducible by Cytokines/Trophic Factors | 1.5 | 15 | Citations (PDF) |
| 137 | Mono and Dually Decorated Nanoliposomes for Brain Targeting, In Vitro and In Vivo Studies | 2.5 | 71 | Citations (PDF) |
| 138 | Applications of Surface Plasmon Resonance (SPR) for the Characterization of Nanoparticles Developed for Biomedical Purposes | 2.3 | 67 | Citations (PDF) |
| 139 | Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis | 1.4 | 73 | Citations (PDF) |
| 140 | New mutations in MAPT gene causing frontotemporal lobar degeneration: biochemical and structural characterization | 2.4 | 32 | Citations (PDF) |
| 141 | Specific Recognition of Biologically Active Amyloid-β Oligomers by a New Surface Plasmon Resonance-based Immunoassay and an in Vivo Assay in Caenorhabditis elegans | 1.3 | 58 | Citations (PDF) |
| 142 | β‐Amyloid 1‐42 induces physiological transcriptional regulation of BACE1 | 2.7 | 23 | Citations (PDF) |
| 143 | Good gene, bad gene: New APP variant may be both | 2.7 | 34 | Citations (PDF) |
| 144 | Huprine–Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer’s and Prion Diseases | 4.0 | 95 | Citations (PDF) |
| 145 | In Vitro Aggregation Behavior of a Non-Amyloidogenic λ Light Chain Dimer Deriving from U266 Multiple Myeloma Cells | 1.5 | 21 | Citations (PDF) |
| 146 | The effect of chewing gum on gastric fluid volume and pH in healthy subjects | 0.6 | 4 | Citations (PDF) |
| 147 | Colloidal stability of polymeric nanoparticles in biological fluids | 2.3 | 174 | Citations (PDF) |
| 148 | Longitudinal Tracking of Human Fetal Cells Labeled with Super Paramagnetic Iron Oxide Nanoparticles in the Brain of Mice with Motor Neuron Disease | 1.5 | 33 | Citations (PDF) |
| 149 | C. elegans Expressing Human β2-Microglobulin: A Novel Model for Studying the Relationship between the Molecular Assembly and the Toxic Phenotype | 1.5 | 24 | Citations (PDF) |
| 150 | Pyrroloquinoxaline hydrazones as fluorescent probes for amyloid fibrils | 1.8 | 63 | Citations (PDF) |
| 151 | Tetracycline prevents Aβ oligomer toxicity through an atypical supramolecular interaction | 1.8 | 56 | Citations (PDF) |
| 152 | Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide | 2.8 | 98 | Citations (PDF) |
| 153 | Curcumin derivatives as new ligands of Aβ peptides | 2.8 | 35 | Citations (PDF) |
| 154 | The Molecular Assembly of Amyloid Aβ Controls Its Neurotoxicity and Binding to Cellular Proteins | 1.5 | 39 | Citations (PDF) |
| 155 | Interaction of the Anticonvulsants, Denzimol and Nafimidone, with Liver Cytochrome P450 in the Rat | 2.5 | 0 | Citations (PDF) |
| 156 | Interactions of the prion peptide (PrP 106-126) with brain capillary endothelial cells: coordinated cell killing and remodeling of intercellular junctions | 2.7 | 11 | Citations (PDF) |
| 157 | Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model | 2.3 | 173 | Citations (PDF) |
| 158 | cis-Glyco-fused benzopyran compounds as new amyloid-β peptide ligands | 2.4 | 46 | Citations (PDF) |
| 159 | Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide | 9.5 | 227 | Citations (PDF) |
| 160 | Use of surface plasmon resonance to study the elongation kinetics and the binding properties of the highly amyloidogenic Aβ1–42 peptide, synthesized by depsi-peptide technique | 8.0 | 38 | Citations (PDF) |
| 161 | A modified protocol to prepare seed-free starting solutions of amyloid-β (Aβ)1–40 and Aβ1–42 from the corresponding depsipeptides | 2.0 | 43 | Citations (PDF) |
| 162 | The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue | 9.5 | 86 | Citations (PDF) |
| 163 | Effect of Tetracyclines on the Dynamics of Formation and Destructuration of β2-Microglobulin Amyloid Fibrils | 1.3 | 99 | Citations (PDF) |
| 164 | Expression of Mutant or Cytosolic PrP in Transgenic Mice and Cells Is Not Associated with Endoplasmic Reticulum Stress or Proteasome Dysfunction | 1.5 | 33 | Citations (PDF) |
| 165 | Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features | 5.8 | 71 | Citations (PDF) |
| 166 | Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomers | 3.5 | 109 | Citations (PDF) |
| 167 | Solid-state stability studies of cholecystokinin (CCK-4) peptide under nonisothermal conditions using thermal analysis, chromatography and mass spectrometry | 3.3 | 7 | Citations (PDF) |
| 168 | Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide | 9.5 | 213 | Citations (PDF) |
| 169 | Mutant Prion Protein Expression Is Associated with an Alteration of the Rab GDP Dissociation Inhibitor α (GDI)/Rab11 Pathway | 3.2 | 37 | Citations (PDF) |
| 170 | Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein | 5.2 | 456 | Citations (PDF) |
| 171 | New Method Based on Capillary Electrophoresis with Laser-Induced Fluorescence Detection (CE-LIF) to Monitor Interaction between Nanoparticles and the Amyloid-β Peptide | 5.2 | 53 | Citations (PDF) |
| 172 | A New Fluorogenic Peptide Determines Proteasome Activity in Single Cells | 4.0 | 22 | Citations (PDF) |
| 173 | Characterization of Detergent-Insoluble Proteins in ALS Indicates a Causal Link between Nitrative Stress and Aggregation in Pathogenesis | 1.5 | 109 | Citations (PDF) |
| 174 | Glimepiride Reduces the Expression of PrPC, Prevents PrPSc Formation and Protects against Prion Mediated Neurotoxicity | 1.5 | 25 | Citations (PDF) |
| 175 | JNK regulates APP cleavage and degradation in a model of Alzheimer's disease | 3.5 | 153 | Citations (PDF) |
| 176 | Spontaneous β‐helical fold in prion protein: The case of PrP(82‐146) | 1.9 | 6 | Citations (PDF) |
| 177 | The SIRT1 activator resveratrol protects SK‐N‐BE cells from oxidative stress and against toxicity caused by α‐synuclein or amyloid‐β (1‐42) peptide | 2.7 | 262 | Citations (PDF) |
| 178 | Proteomic Profiling of Cervical and Lumbar Spinal Cord Reveals Potential Protective Mechanisms in the Wobbler Mouse, a Model of Motor Neuron Degeneration | 2.2 | 15 | Citations (PDF) |
| 179 | c-Jun N-terminal kinase binding domain–dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons | 1.8 | 38 | Citations (PDF) |
| 180 | Acetylcholinesterase as an amyloid enhancing factor in PrP82-146 aggregation process | 2.2 | 26 | Citations (PDF) |
| 181 | Overcoming synthetic Aβ peptide aging: a new approach to an age-old problem | 2.6 | 37 | Citations (PDF) |
| 182 | Polyunsaturated Fatty Acids Protect Against Prion-Mediated Synapse Damage In Vitro | 2.4 | 13 | Citations (PDF) |
| 183 | The anti-fibrillogenic activity of tetracyclines on PrP 106–126: a 3D-QSAR study | 1.9 | 20 | Citations (PDF) |
| 184 | Conformational Plasticity of the Gerstmann–Sträussler–Scheinker Disease Peptide as Indicated by Its Multiple Aggregation Pathways | 2.9 | 56 | Citations (PDF) |
| 185 | Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82–146 and Aβ1–42 | 3.0 | 22 | Citations (PDF) |
| 186 | Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells | 3.0 | 14 | Citations (PDF) |
| 187 | The Efficacy of Tetracyclines in Peripheral and Intracerebral Prion Infection | 1.5 | 104 | Citations (PDF) |
| 188 | Neurotoxic and Gliotrophic Activity of a Synthetic Peptide Homologous to Gerstmann-Straussler-Scheinker Disease Amyloid Protein | 2.3 | 37 | Citations (PDF) |
| 189 | Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse | 1.5 | 77 | Citations (PDF) |
| 190 | Cytoplasmic Domain of Human Myelin Protein Zero Likely Folded as β-Structure in Compact Myelin | 1.5 | 38 | Citations (PDF) |
| 191 | Cytoplasmic Domain of Zebrafish Myelin Protein Zero: Adhesive Role Depends on β-Conformation | 1.5 | 10 | Citations (PDF) |
| 192 | Aggregation/Fibrillogenesis of Recombinant Human Prion Protein and Gerstmann−Sträussler−Scheinker Disease Peptides in the Presence of Metal Ions | 1.5 | 38 | Citations (PDF) |
| 193 | Conformational Polymorphism of the PrP106−126 Peptide in Different Environments: A Molecular Dynamics Study | 2.0 | 37 | Citations (PDF) |
| 194 | Acetylcholinesterase triggers the aggregation of PrP 106–126 | 1.5 | 24 | Citations (PDF) |
| 195 | Redox regulation of cyclophilin A by glutathionylation | 2.1 | 45 | Citations (PDF) |
| 196 | Analysis of the cerebellar proteome in a transgenic mouse model of inherited prion disease reveals preclinical alteration of calcineurin activity | 2.1 | 19 | Citations (PDF) |
| 197 | Effect of Acetylcholinesterase Inhibitors on AChE-Induced PrP106-126 Aggregation | 1.4 | 6 | Citations (PDF) |
| 198 | Gα13 mediates activation of the cytosolic phospholipase A2α through fine regulation of ERK phosphorylation | 2.7 | 21 | Citations (PDF) |
| 199 | Insoluble Mutant SOD1 Is Partly Oligoubiquitinated in Amyotrophic Lateral Sclerosis Mice | 1.3 | 93 | Citations (PDF) |
| 200 | Gerstmann-Sträussler-Scheinker Disease Amyloid Protein Polymerizes According to the “Dock-and-Lock” Model | 1.3 | 33 | Citations (PDF) |
| 201 | Protein Nitration in a Mouse Model of Familial Amyotrophic Lateral Sclerosis | 1.3 | 173 | Citations (PDF) |
| 202 | The neurotoxicity of prion protein (PrP) peptide 106–126 is independent of the expression level of PrP and is not mediated by abnormal PrP species | 2.2 | 57 | Citations (PDF) |
| 203 | Regulation and Biochemistry of Mouse Molybdo-flavoenzymes | 1.3 | 42 | Citations (PDF) |
| 204 | Squalestatin Cures Prion-infected Neurons and Protects Against Prion Neurotoxicity | 1.3 | 127 | Citations (PDF) |
| 205 | The Aldehyde Oxidase Gene Cluster in Mice and Rats | 1.3 | 59 | Citations (PDF) |
| 206 | An in vitro screening assay based on synthetic prion protein peptides for identification of fibril-interfering compounds | 2.0 | 24 | Citations (PDF) |
| 207 | Title is missing! | 6.1 | 75 | Citations (PDF) |
| 208 | The role of platelet activating factor in prion and amyloid-β neurotoxicity | 1.2 | 39 | Citations (PDF) |
| 209 | Tetracycline and its analogues as inhibitors of amyloid fibrils: searching for a geometrical pharmacophore by theoretical investigation of their conformational behavior in aqueous solution | 1.9 | 22 | Citations (PDF) |
| 210 | Quinacrine blocks PrP (106-126)-formed channels | 2.0 | 21 | Citations (PDF) |
| 211 | Therapeutic approaches to prion diseases | 0.9 | 14 | Citations (PDF) |
| 212 | Evaluation of Quinacrine Treatment for Prion Diseases | 2.4 | 202 | Citations (PDF) |
| 213 | Structural Properties of Gerstmann-Sträussler-Scheinker Disease Amyloid Protein | 1.3 | 77 | Citations (PDF) |
| 214 | In vitro Evaluation of the Anti-prionic Activity of Newly Synthesized Congo Red Derivatives | 0.8 | 17 | Citations (PDF) |
| 215 | Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients | 2.9 | 54 | Citations (PDF) |
| 216 | Glutathionylation of human thioredoxin: A possible crosstalk between the glutathione and thioredoxin systems | 5.2 | 336 | Citations (PDF) |
| 217 | Tetracyclines affect prion infectivity | 5.2 | 200 | Citations (PDF) |
| 218 | Synthetic Miniprion PrP106 | 1.3 | 32 | Citations (PDF) |
| 219 | Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes | 5.2 | 557 | Citations (PDF) |
| 220 | Wax Esters of n -3 Polyunsaturated Fatty Acids: A New Stable Formulation as a Potential Food Supplement. 1 — Digestion and Absorption in Rats | 4.7 | 34 | Citations (PDF) |
| 221 | Characterization of antimalarial SPf66 peptide using MALDI–TOF MS, CD and SEC | 2.0 | 5 | Citations (PDF) |
| 222 | Anti‐amyloidogenic activity of tetracyclines: studies in vitro | 1.8 | 224 | Citations (PDF) |
| 223 | Studies on peptide fragments of prion proteins | 5.3 | 42 | Citations (PDF) |
| 224 | Purification of the Aldehyde Oxidase Homolog 1 (AOH1) Protein and Cloning of the AOH1 and Aldehyde Oxidase Homolog 2 (AOH2) Genes | 1.3 | 44 | Citations (PDF) |
| 225 | The Stimulation of Inducible Nitric-oxide Synthase by the Prion Protein Fragment 106–126 in Human Microglia Is Tumor Necrosis Factor-α-dependent and Involves p38 Mitogen-activated Protein Kinase | 1.3 | 62 | Citations (PDF) |
| 226 | A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V | 1.3 | 123 | Citations (PDF) |
| 227 | Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins | 1.8 | 292 | Citations (PDF) |
| 228 | Cloning of the cDNAs Coding for Two Novel Molybdo-flavoproteins Showing High Similarity with Aldehyde Oxidase and Xanthine Oxidoreductase | 1.3 | 61 | Citations (PDF) |
| 229 | INHIBITION OF HMG-CoA REDUCTASE ACTIVITY BY HYPERCHOLESTEROLAEMIA REDUCES LEUKOCYTE RECRUITMENT AND MCP-1 PRODUCTION | 2.0 | 12 | Citations (PDF) |
| 230 | Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro11Edited by J. Karn | 2.9 | 167 | Citations (PDF) |
| 231 | Apoptotic Cell Death and Impairment of L-Type Voltage-Sensitive Calcium Channel Activity in Rat Cerebellar Granule Cells Treated with the Prion Protein Fragment 106–126 | 3.5 | 66 | Citations (PDF) |
| 232 | Measurement of intracellular calcium levels by the fluorescent Ca2+ indicator Calcium-Green | 1.6 | 13 | Citations (PDF) |
| 233 | Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106–126 | 1.0 | 56 | Citations (PDF) |
| 234 | Molecular Cloning and Functional Characterization of Brefeldin A-ADP-ribosylated Substrate | 1.3 | 97 | Citations (PDF) |
| 235 | Determination of solution conformations of PrP106-126, a neurotoxic fragment of prion protein, by1H NMR and restrained molecular dynamics | 0.2 | 33 | Citations (PDF) |
| 236 | CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid | 30.7 | 325 | Citations (PDF) |
| 237 | Activation of microglial cells by PrP and β-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels | 1.9 | 109 | Citations (PDF) |
| 238 | Influence of mutations associated with familial prion-related encephalopathies on biological activity of prion protein peptides | 4.6 | 20 | Citations (PDF) |
| 239 | Characterization of type II intracellular IL-1 receptor antagonist (IL-1ra3): a depot IL-1ra | 2.2 | 30 | Citations (PDF) |
| 240 | Localization and age-dependent expression of the inward rectifier K+
channel subunit Kir 5.1 in a mammalian reproductive system | 1.8 | 42 | Citations (PDF) |
| 241 | Oleamide-mediated sleep induction does not depend on perturbation of membrane homeoviscosity | 1.8 | 10 | Citations (PDF) |
| 242 | A βPP Peptide Carboxyl-Terminal to Aβ Is Neurotoxic | 2.8 | 20 | Citations (PDF) |
| 243 | Alteration of SREBP Activation in Liver of Trisomy 21 Fetuses | 1.5 | 13 | Citations (PDF) |
| 244 | Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106–126 | 2.3 | 102 | Citations (PDF) |
| 245 | Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines | 1.2 | 109 | Citations (PDF) |
| 246 | Prion protein fragment 106-126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell line 1998, 54, 341-352 | | 76 | Citations (PDF) |
| 247 | Rapid solid-phase extraction method for automated gas chromatographic–mass spectrometric determination of nicotine in plasma | 1.9 | 19 | Citations (PDF) |
| 248 | Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3 | 1.3 | 370 | Citations (PDF) |
| 249 | A Neurotoxic and Gliotrophic Fragment of the Prion Protein Increases Plasma Membrane Microviscosity | 3.5 | 60 | Citations (PDF) |
| 250 | [[(Arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone Derivatives as High-Affinity, Selective 5-HT1AReceptor Ligands† | 4.0 | 68 | Citations (PDF) |
| 251 | Identification of a Short Sequence Highly Divergent Between beta-Adrenergic-Receptor Kinases 1 and 2 that Determines the Affinity of Binding to betagamma Subunits of Heterotrimeric Guanine-Nucleotide-Binding Regulatory Proteins | 0.2 | 11 | Citations (PDF) |
| 252 | Spectroscopic and binding studies on the interaction of inorganic anions with lactoperoxidase | 2.3 | 45 | Citations (PDF) |
| 253 | Amidation of β‐Amyloid Peptide Strongly Reduced the Amyloidogenic Activity Without Alteration of the Neurotoxicity | 2.7 | 36 | Citations (PDF) |
| 254 | Amyloid in alzheimer's disease and prion-related encephalopathies: Studies with synthetic peptides | 2.7 | 54 | Citations (PDF) |
| 255 | Intracellular Calcium Rise through L-Type Calcium Channels, as Molecular Mechanism for Prion Protein Fragment 106-126-Induced Astroglial Proliferation | 1.5 | 77 | Citations (PDF) |
| 256 | In vivo exposure to NO2 reduces TNF and IL-6 production by endotoxin-stimulated alveolar macrophages | 2.2 | 6 | Citations (PDF) |
| 257 | Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes | 2.3 | 52 | Citations (PDF) |
| 258 | A theoretical three-dimensional model for lactoperoxidase and eosinophil peroxidase, built on the scaffold of the myeloperoxidase X-ray structure | 1.7 | 36 | Citations (PDF) |
| 259 | Apoptosis-mediated neurotoxicity induced by β-amyloid and PRP fragments | 0.9 | 90 | Citations (PDF) |
| 260 | Clusterin (SGP-2) Induction in Rat Astroglial Cells Exposed to Prion Protein Fragment 106-126 | 1.6 | 38 | Citations (PDF) |
| 261 | β25–35 Alters Calcium Homeostasis and Induces Neurotoxicity in Cerebellar Granule Cells | 2.7 | 38 | Citations (PDF) |
| 262 | A PRION PROTEIN FRAGMENT MODIFIES PLASMA MEMBRANE VISCOSITY AND INTRACELLULAR. CALCIUM LEVEL | 1.4 | 3 | Citations (PDF) |
| 263 | Manganese Peroxidase from Phanerochaete chrysosporium. A Homology-Based Molecular Model | 0.2 | 3 | Citations (PDF) |
| 264 | Basic proteins and basic membranes adjusting blotting and staining conditions to immobilon CD | 2.8 | 2 | Citations (PDF) |
| 265 | Purification, cDNA Cloning, and Tissue Distribution of Bovine Liver Aldehyde Oxidase | 1.3 | 98 | Citations (PDF) |
| 266 | Phosphatidic Acid and Lysophosphatidic Acid Induce Haptotactic Migration of Human Monocytes | 1.3 | 93 | Citations (PDF) |
| 267 | Reye's and Reye-Like Syndromes, Drug-Related Diseases? (Causative Agents, Etiology, Pathogenesis, and Therapeutic Approaches) | 2.6 | 30 | Citations (PDF) |
| 268 | Extracellular glutamate levels in the hypothalamus and hippocampus of rats after acute or chronic oral intake of monosodium glutamate | 1.3 | 26 | Citations (PDF) |
| 269 | Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver. | 2.0 | 0 | Citations (PDF) |
| 270 | Biochemical effects of acute and subacute nitrogen dioxide exposure in rat lung and bronchoalveolar lavage fluid | 1.5 | 7 | Citations (PDF) |
| 271 | The Purification of Histones by Metal-Chelate Chromatography | 2.0 | 2 | Citations (PDF) |
| 272 | The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leukemic cells | 2.8 | 43 | Citations (PDF) |
| 273 | In vivo anti-tumor activity of synthetic ether lipids is not enhanced by pharmacological modulation of tumor lipid composition | 2.8 | 1 | Citations (PDF) |
| 274 | An automated system for animal exposure to nitrogen dioxide | 1.4 | 1 | Citations (PDF) |
| 275 | A Neurotoxic Prion Protein Fragment Induces Rat Astroglial Proliferation and Hypertrophy | 1.6 | 114 | Citations (PDF) |
| 276 | Solubilization and characterization of d-fenfluramine binding sites from bovine cerebral cortex | 3.7 | 3 | Citations (PDF) |
| 277 | Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. | 1.3 | 175 | Citations (PDF) |
| 278 | Defective glomerular [3H]lysoPAF metabolism in the autologous phase of rabbit nephrotoxic nephritis | 4.2 | 1 | Citations (PDF) |
| 279 | Neurotoxicity of a prion protein fragment | 30.7 | 955 | Citations (PDF) |
| 280 | Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma | 0.9 | 1 | Citations (PDF) |
| 281 | The effect of culture medium composition on ether lipid cytotoxic activity | 0.9 | 14 | Citations (PDF) |
| 282 | The pneumotoxicant paraquat induces IL-8 mRNA in human mononuclear cells and pulmonary epithelial cells | 2.0 | 27 | Citations (PDF) |
| 283 | Molecular Characteristics of a Protease-Resistant, Amyloidogenic and Neurotoxic Peptide Homologous to Residues 106-126 of the Prion Protein | 1.5 | 213 | Citations (PDF) |
| 284 | Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-RAC-glycero-3- phosphocholine. A possible basis for its selective action | 2.8 | 112 | Citations (PDF) |
| 285 | EFFECT OF PAF ANTAGONISTS ON THE CYTOTOXIC ACTIVITY OF ANTINEOPLASTIC ETHER PHOSPHOLIPIDS | 3.6 | 0 | Citations (PDF) |
| 286 | Fetal lung maturity evaluation with fluorescence polarization of the amniotic fluid | 0.9 | 2 | Citations (PDF) |
| 287 | IN VITRO NEUROTOXICITY OF A FRAGMENT OF THE PRION PROTEIN | 1.4 | 0 | Citations (PDF) |
| 288 | Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35 | 1.2 | 359 | Citations (PDF) |
| 289 | MEMBRANE CHOLESTEROL CONTENT AND SENSITIVITY OF HUMAN CARCINOMA-CELLS TO ANTINEOPLASTIC ETHER PHOSPHOLIPIDS | 3.6 | 0 | Citations (PDF) |
| 290 | Phospholipid composition, phosphoinositide metabolism and metastatic capacity in murine melanoma B16 variants at different stages of growth | 1.0 | 6 | Citations (PDF) |
| 291 | A soluble form of prion protein in human cerebrospinal fluid as a potential source of PRP amyloid | 2.4 | 0 | Citations (PDF) |
| 292 | A soluble form of prion protein in human cerebrospinal fluid: Implications for prion-related encephalopathies | 1.5 | 90 | Citations (PDF) |
| 293 | Sinthetic peptides homologous to prion protein fragments form amyloid-like fibrils in vitro | 2.4 | 2 | Citations (PDF) |
| 294 | A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducer | 2.0 | 26 | Citations (PDF) |
| 295 | Modulation of ATPase activity by cholesterol and synthetic ether lipids in leukemic cells | 3.7 | 19 | Citations (PDF) |
| 296 | Synthetic ether lipids fluidizing action and cell membrane lipid composition: A commentary note | 2.8 | 3 | Citations (PDF) |
| 297 | Aging and food restriction: Effect on lipids of cerebral cortex | 2.4 | 55 | Citations (PDF) |
| 298 | Effect of tyrosine on the potentiation by aspartame and phenylalanine of metrazol-induced convulsions in rats | 2.0 | 4 | Citations (PDF) |
| 299 | Interspecies and interstrain studies on the increased susceptibility to metrazol-induced convulsions in animals given aspartame | 2.0 | 16 | Citations (PDF) |
| 300 | Effect of Iodinated Contrast Media on the Synthesis and Metabolism of Leukotriene B4 | 4.3 | 4 | Citations (PDF) |
| 301 | Increased ether lipid cytotoxicity by reducing membrane cholesterol content | 2.8 | 26 | Citations (PDF) |
| 302 | Effect of Iodinated Contrast Media on the Synthesis and Metabolism of Leukotriene B4 | 4.3 | 2 | Citations (PDF) |
| 303 | Fluorescence Polarization Changes with Gestational Age in Amniotic Fluid of Rabbit and Guinea Pig | 1.1 | 0 | Citations (PDF) |
| 304 | Oral zeranol shortens the prolonged bleeding time of uremic rats | 4.2 | 5 | Citations (PDF) |
| 305 | Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity | 2.8 | 56 | Citations (PDF) |
| 306 | Determination of argininosuccinate lyase and arginase activities with an amino acid analyzer | 2.0 | 16 | Citations (PDF) |
| 307 | Interferon inducers increase O6-alkylguanine-DNA alkyltransferase in the rat liver | 2.2 | 16 | Citations (PDF) |
| 308 | Plasma and brain kinetics of large neutral amino acids and of striatum monoamines in rats given aspartame | 2.0 | 14 | Citations (PDF) |
| 309 | Effects of Aspartame and Carbohydrate Administration on Human and Rat Plasma Large Neutral Amino Acid Levels and Rat Brain Amino Acid and Monoamine Levels | 2.3 | 9 | Citations (PDF) |
| 310 | Membrane fluidity affects tumor-cell motility, invasion and lung-colonizing potential | 2.8 | 114 | Citations (PDF) |
| 311 | Effect of aspartame on seizures in various models of experimental epilepsy | 2.2 | 14 | Citations (PDF) |
| 312 | Liver DNA alkylation after a single carcinogenic dose of dimethylnitrosamine to newborn and adult CFW Swiss mice | 3.2 | 23 | Citations (PDF) |
| 313 | A rapid electrochemical assay of lecithin in amniotic fluid using a fluoride ion-sensitive electrode | 0.7 | 5 | Citations (PDF) |
| 314 | Differential effects of benzodiazepines on phospholipid methylation in hippocampus and cerebellum of rats | 3.7 | 3 | Citations (PDF) |
| 315 | Aspartame and the rat brain monoaminergic system | 0.4 | 19 | Citations (PDF) |
| 316 | Letters to the Editors | 0.9 | 2 | Citations (PDF) |
| 317 | Defective Production of Reactive Oxygen Intermediates by Tumor-Associated Macrophages Exposed to Phorbol Ester | 1.7 | 9 | Citations (PDF) |
| 318 | Measurement of fetal surfactant production by fluorescence polarization of amniotic fluid in complicated pregnancies | 0.7 | 5 | Citations (PDF) |
| 319 | In vivo studies of rat alveolar macrophase microviscosity: Influence of pulmonary surfactant synthesis stimulation | 1.9 | 4 | Citations (PDF) |
| 320 | DNA synthesis, mitotic index, drug-metabolising systems and cytogenetic analysis in regenerating rat liver | 0.3 | 21 | Citations (PDF) |
| 321 | Determination of fetal lung maturity in rats by fluorescence polarization | 3.7 | 3 | Citations (PDF) |
| 322 | Gentisic acid: an aspirin metabolite with multiple effects on human blood polymorphonuclear leukocytes | 3.7 | 23 | Citations (PDF) |
| 323 | N-acetyl-β-d-glucosaminidase (NAG) levels in amniotic fluid or urine in prenatal and postnatal life | 1.2 | 9 | Citations (PDF) |
| 324 | Biochemical characterization of the hepatic effects in mice and rats of 1,4-bis62-(3,5-dichloropyridyloxy)9benzene, a hepatic neoplasm promoter | 2.2 | 11 | Citations (PDF) |
| 325 | The rate ofN-demethylation ofN,N-dimethylanilines andN-methylanilines by rat-liver microsomes is related to their first ionization potential, their lipophilicity and to a steric bulk factor | 0.9 | 31 | Citations (PDF) |
| 326 | Prostaglandins and aminoglycoside nephrotoxicity | 2.2 | 19 | Citations (PDF) |
| 327 | Tumor-derived chemotactic factor(S) from human ovarian carcinoma: Evidence for a role in the regulation of macrophage content of neoplastic tissues | 2.8 | 60 | Citations (PDF) |
| 328 | Platelet derived growth factor induces ornithine decarboxylase activity in nih 3T3 cells | 1.5 | 11 | Citations (PDF) |
| 329 | Kinetics of monosodium glutamate in human volunteers under different experimental conditions | 2.0 | 9 | Citations (PDF) |
| 330 | Intact human lymphocyte membranes respond to muscarinic receptor stimulation by oxotremorine with marked changes in microviscosity and an increase in cyclic GMP | 1.8 | 23 | Citations (PDF) |
| 331 | Structure reactivity relationships in the microsomal oxidation of tertiary amines | 1.4 | 17 | Citations (PDF) |
| 332 | Different susceptibility of mouse tissues to porphyrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin | 0.4 | 8 | Citations (PDF) |
| 333 | Diazepam increases membrane fluidity of rat hippocampus synaptosomes | 1.8 | 27 | Citations (PDF) |
| 334 | Characterization of arachidonic acid metabolic profiles in animal tissues by high-resolution gas chromatography-mass spectrometry | 2.5 | 21 | Citations (PDF) |
| 335 | Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers | 1.5 | 85 | Citations (PDF) |
| 336 | Kinetics of 3-tert-butyl-4-hydroxyanisole (BHA) in man | 2.0 | 14 | Citations (PDF) |
| 337 | Perinatal development of styrene monooxygenase and epoxide hydrolase in rat liver microsomes and nuclei | 3.2 | 7 | Citations (PDF) |
| 338 | Mutagenic relevance of rat hepatocyte nuclei in the activation and inactivation of xenobiotica cyclophosphamide and epichlorohydrin activity on the yeasts S. pombe and S. cerevisiae | 1.2 | 2 | Citations (PDF) |
| 339 | Evaluation of epichlorohydrin (ECH) genotoxicity | 1.2 | 12 | Citations (PDF) |
| 340 | Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: Evidence for a role in the regulation of the macrophage content of neoplastic tissues | 2.8 | 56 | Citations (PDF) |
| 341 | The influence of selenium intake on chronic adriamycin toxicity and lipid peroxidation in rats | 0.4 | 25 | Citations (PDF) |
| 342 | Plasma pyroglutamic acid levels after oral administration of monosodium glutamate to human volunteers | 0.4 | 13 | Citations (PDF) |
| 343 | Pyroglutamate kinetics and neurotoxicity studies in mice | 0.4 | 9 | Citations (PDF) |
| 344 | Toxicological evaluation of urban waste incinerator emissions | 5.0 | 18 | Citations (PDF) |
| 345 | N-Acetyl-β-d-glucosaminidase (NAG) and NAG isoenzymes in children with upper and lower urinary tract infections | 0.7 | 28 | Citations (PDF) |
| 346 | Is There a Role for Nuclei in the Metabolism of Xenobiotica? A Review | 2.6 | 24 | Citations (PDF) |
| 347 | Further studies on adriamycin induced in vitro lipid peroxidation | 3.2 | 13 | Citations (PDF) |
| 348 | Perinatal development of cytochrome P-450, nadphcytochrome c reductase and ethoxycoumarin deethylase in rat liver nuclear membranes | 3.2 | 7 | Citations (PDF) |
| 349 | Determination of dipeptides in protein hydrolysates for total parenteral nutrition | 2.8 | 5 | Citations (PDF) |
| 350 | Methodological and clinical aspects of urinary N-acetyl-glucosaminidase in pediatric subjects | 0.5 | 23 | Citations (PDF) |
| 351 | Plasma kinetics and urinary elimination of saccharin in man | 0.4 | 9 | Citations (PDF) |
| 352 | GLC-mass Fragmentographic Determination of Saccharin in Biological Fluids | 2.4 | 3 | Citations (PDF) |
| 353 | Induction of nuclear styrene monooxygenase and epoxide hydrolase in rat liver | 0.3 | 2 | Citations (PDF) |
| 354 | Induction of mixed-function oxidase by chronic treatment with 2,3,7,8-tetrachloro-dibenzo-p-dioxin in female rats | 3.1 | 6 | Citations (PDF) |
| 355 | Porphyrogenic effect of chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in female rats. Dose-effect relationship following urinary excretion of porphyrins | 2.2 | 41 | Citations (PDF) |
| 356 | Nuclear metabolism. II. Further studies on epoxide hydrolase activity | 3.2 | 11 | Citations (PDF) |
| 357 | Improved gas chromatographic method for measuring phenylethylene glycol | 2.8 | 20 | Citations (PDF) |
| 358 | Is nuclear styrene monooxygenase activity a microsomal artifact? | 3.2 | 9 | Citations (PDF) |
| 359 | Nuclear metabolism. I. Determination of styrene monooxygenase activity in rat liver nuclei | 3.2 | 11 | Citations (PDF) |
| 360 | Non-linear kinetics of microsomal styrene monooxygenase after phenobarbital pre-treatment | 0.3 | 5 | Citations (PDF) |
| 361 | Monosodium glutamate kinetic studies in human volunteers | 0.4 | 16 | Citations (PDF) |
| 362 | Effect of oral monosodium glutamate on glutamic acid levels in the nucleus arcuatus of the hypothalamus and on serum osmolality of adult and infant mice | 0.4 | 12 | Citations (PDF) |
| 363 | Effects of chronic treatment with DI-(2-ethylhexyl) phthalate on rat liver microsomal activities | 0.4 | 5 | Citations (PDF) |
| 364 | In vitro effects of saccharin on cell-mediated host defence mechanisms | 0.4 | 10 | Citations (PDF) |
| 365 | Plasma glutamic acid levels in premature newborn | 0.4 | 1 | Citations (PDF) |
| 366 | Quantitative gas-liquid chromatographic determination of ftorafur and 5-fluorouracil in biological specimens | 2.0 | 12 | Citations (PDF) |
| 367 | Quantitative thin-layer chromatographic measurement of N-trifluoroacetyladriamycin-14-valerate (AD 32) and trifluoroacetyladriamycin (AD 41) in blood and tissues | 1.9 | 7 | Citations (PDF) |
| 368 | Ftorafur: A self-limiting source of 5-fluorouracil? | 1.3 | 10 | Citations (PDF) |
| 369 | Decreased half life of cyclophosphamide in patients under continual treatment | 0.9 | 65 | Citations (PDF) |
| 370 | Isolation and structure determination of enzymatically formed styrene oxide glutathione conjugates | 3.2 | 25 | Citations (PDF) |
| 371 | Esterase activity of rat muscle | 1.4 | 3 | Citations (PDF) |
| 372 | Glutamic acid and sodium levels in the nucleus arcuatus of the hypothalamus of adult and infant rats after oral monosodium glutamate | 0.4 | 7 | Citations (PDF) |
| 373 | The absorption by human volunteers of glutamic acid from monosodium glutamate and from a partial enzymic hydrolysate of casein | 3.1 | 15 | Citations (PDF) |
| 374 | Simple and sensitive method for the determination of cyclophosphamide by means of a nitrogen—phosphorus-selective detector | 1.9 | 19 | Citations (PDF) |
| 375 | Intercalation with DNA is a prerequisite for Daunomycin, Adriamycin and its congeners in inhibiting DNAase I | 3.2 | 28 | Citations (PDF) |
| 376 | Degradation of 2,3,7,8-tetrachlorodibenzo-p-dioxin in organic solvents by gamma ray irradiation | 0.3 | 8 | Citations (PDF) |
| 377 | The oral administration of msg at varying concentrations to male mice | 0.4 | 4 | Citations (PDF) |
| 378 | Uptake of glutamate in beagle dogs after oral gavage with MSG | 0.4 | 6 | Citations (PDF) |
| 379 | Hepatic and extrahepatic formation and hydration of styrene oxide in vitro in animals of different species and sex | 0.4 | 59 | Citations (PDF) |
| 380 | Serum glutamate in rhesus macaques after gavage with MSG | 0.4 | 6 | Citations (PDF) |
| 381 | Kinetics of monosodium glutamate in relation to its neurotoxicity | 0.4 | 27 | Citations (PDF) |
| 382 | Effect of daunomycin, adriamycin and its congener AD 32 on the activity of DNase I from bovine pancreas | 3.7 | 9 | Citations (PDF) |
| 383 | Inhibition of liver microsomal epoxide hydrase by cyproheptadine epoxide | 0.3 | 3 | Citations (PDF) |
| 384 | Kinetic behaviour of microsomal styrene monooxygenase and styrene epoxide hydratase in different animal species | 0.3 | 20 | Citations (PDF) |
| 385 | In vitro binding and metabolism of iopronic acid by rat liver microsomes | 0.1 | 11 | Citations (PDF) |
| 386 | Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition | 2.2 | 51 | Citations (PDF) |
| 387 | A specific gas chromatographic method for the determination of microsomal styrene monooxygenase and styrene epoxide hydratase activities | 2.8 | 61 | Citations (PDF) |
| 388 | Microsomal Styrene Mono-oxygenase and Styrene Epoxide Hydrase Activities in Rats | 0.9 | 43 | Citations (PDF) |
| 389 | Activity of liver microsomal mono-oxygenases on some epoxide-forming tricyclic drugs. I. Kineticsin vitro | 0.9 | 14 | Citations (PDF) |
| 390 | Gas chromatographic-mass spectrometric determination of intact C3-hydroxylated benzodiazepine glucuronides in urine | 2.8 | 15 | Citations (PDF) |
| 391 | In Vitro Hydrolysis of Oxazepam Succinate Half-Ester by a Stereospecific Soluble Esterase from Different Animal Species | 2.4 | 29 | Citations (PDF) |
